These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 734088)

  • 41. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microfluorometric comparisons of chromatin thermal stability in situ between normal and neoplastic cells.
    Alvarez MR
    Cancer Res; 1973 Apr; 33(4):786-90. PubMed ID: 4696478
    [No Abstract]   [Full Text] [Related]  

  • 43. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro.
    Lehmann W; Graetz H; Widmayer R; Langen P
    Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell cycle time, growth fraction and cell loss in xenografted head and neck cancer.
    Zätterström UK; Källén A; Wennerberg J
    In Vivo; 1991; 5(2):137-42. PubMed ID: 1768782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of nitrogen derivative of verrucarin E, VER-I, on biology and development of morphological, histochemical and histoenzymatic changes in experimental neoplasms in animals].
    Jodczyk KJ
    Patol Pol; 1984; 35(3):349-64. PubMed ID: 6535083
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
    Mazureka C; Stiffel C; Chalvet H; Biozzi G
    C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
    Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
    Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Computerized models of the variation of the different stages of the cell cycle in a hypertriploid Ehrlich ascites tumor in the early days after implantation].
    Pertusa J; Vives F; Pellicer J
    Rev Esp Oncol; 1982; 29(3):463-71. PubMed ID: 6927017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between tumor growth characteristics and preferential sites of growth.
    Vaage J
    J Natl Cancer Inst; 1984 May; 72(5):1199-203. PubMed ID: 6585595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study of the effect of acid mucopolysaccharides on the growth of experimental tumors in mice.
    Shohat B; Allalouf D; Ber A
    Pathol Biol (Paris); 1973 Feb; 21(2):117-22. PubMed ID: 4266993
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of selenium and low levels of lead on mammary tumor development and growth in MMTV-infected female mice.
    Schrauzer GN
    Biol Trace Elem Res; 2008 Dec; 125(3):268-75. PubMed ID: 18726561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms underlying reduced growth rate in C3HBA mammary adenocarcinomas recurring after single doses of x-rays or fast neutrons.
    Nelson JS; Carpenter RE; Durboraw D
    Cancer Res; 1976 Feb; 36(2 Pt 1):524-31. PubMed ID: 1260751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism of purine and pyrimidine compounds in erythrocytes of tumor-bearing mice.
    Tikhonov YV; Pimenov AM; Toguzov RT; Grune T; Siems W; Schmidt H; Gerber G
    Biomed Biochim Acta; 1990; 49(2-3):S125-8. PubMed ID: 2386497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alteration of tumor cell and hepatic parenchymal cell mitotic rates in tumor-injected partially hepatectomized mice.
    Rosene GL
    Cancer Res; 1968 Aug; 28(8):1469-77. PubMed ID: 4876976
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of 3,5,3'-triiodo-L-thyronine on the incidence and growth kinetics of spontaneous mammary tumors in C3H/HeN mice.
    Sellitti DF; Tseng YC; Latham KR
    Cancer Res; 1981 Dec; 41(12 Pt 1):5015-9. PubMed ID: 7307003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Kinetic study of a heterogeneous tumor cell population using a mathematical model].
    Orkina EL
    Tsitologiia; 1979 Oct; 21(10):1181-9. PubMed ID: 505568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Biological action of a constant magnetic field on the hematopoietic system of intact animals and animals with tumors].
    Savchik AB; Savchuk LF; Ivasivka SV; Savchik BA
    Probl Gematol Pereliv Krovi; 1979 Mar; 24(3):58-60. PubMed ID: 432229
    [No Abstract]   [Full Text] [Related]  

  • 58. Kinetic models of C3H mouse mammary tumor growth: implications regarding tumor cell loss.
    Roti JL; Bohling V; Dethlefsen LA
    Cell Tissue Kinet; 1978 Jan; 11(1):1-21. PubMed ID: 624115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of an inhibiting factor of epidermal proliferation in plucked skin and various tumours of mice.
    Guigon M; Frindel E; Hewitt J; Tubiana M
    Br J Dermatol; 1976 Aug; 95(2):131-5. PubMed ID: 133707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new principle of specificity in anaerobic infections--mathematical model of mitosis-stimulated bacterial growth. The application of the tumor-tetanus phenomenon.
    Schmidt W; Schneeweiss U; Fabricius EM
    J Theor Biol; 1980 Oct; 86(4):783-802. PubMed ID: 7019576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.